ARTICLE | Company News
BioKeys Inc., BioQuest deal
February 28, 2000 8:00 AM UTC
The companies signed a letter of intent to merge, retaining the BioKeys name. BioKeys' Co-factor, which enhances treatment with 5-fluorouracil (5-FU) in colorectal and breast cancer, is about to begin...